Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies
Cancer Cell · 2026-09 · 44 (9) · 1815-1831.e11
DOI: 10.1016/j.ccell.2026.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-09. Verfasst von R Ryan Meyerhoff und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: meyerhr…. Hauptthemen laut MEDLINE: Plasma Cells, Programmed Cell Death 1 Receptor, Lung Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Interventional Radiology, Department of Radiology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: meyerhr@mskcc.org.
- Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27710, USA.
- Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.
- Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health National Cancer Institute
Zitieren
APA
Meyerhoff, R. R., Chen, A., O'Brien, J., Anadon, C. M., Lopez Bailon, L. U., Carrion-Estrada, D., Poysungnoen, K., Lindenberger, J., Kemeny, G., Lyniv, L., Jain, V., Chaurio, R., Plappert, N., Evangelous, T., Park, C. S., Sinha, A., Oduah, E., Glass, C., Weinhold, K., …, & Antonia, S. J. (2026). Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies. Cancer Cell, 44(9), 1815-1831.e11. https://doi.org/10.1016/j.ccell.2026.07.001
Vancouver
Meyerhoff RR, Chen A, O'Brien J, Anadon CM, Lopez Bailon LU, Carrion-Estrada D, et al. Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies. Cancer Cell. 2026;44(9):1815-1831.e11. doi:10.1016/j.ccell.2026.07.001
BibTeX
@article{Meyerhoff2026,
author = {Meyerhoff, R Ryan and Chen, Alan and O'Brien, Jenny and Anadon, Carmen M and Lopez Bailon, Luis Uriel and Carrion-Estrada, Dayan and Poysungnoen, Koravit and Lindenberger, Jared and Kemeny, Gabor and Lyniv, Liliana and Jain, Vaibjav and Chaurio, Ricardo and Plappert, Noah and Evangelous, Tyler and Park, Chan Soo and Sinha, Alok and Oduah, Eziafa and Glass, Carolyn and Weinhold, Kent and Gregory, Simon and Hickey, John W and Acharya, Priyamvada and Ready, Neal and Conejo-Garcia, Jose R and Williams, Wilton B and Antonia, Scott J},
title = {Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {9},
pages = {1815--1831.e11},
doi = {10.1016/j.ccell.2026.07.001}
}
EUVIMED